1
|
Lim JH, Kim SE, Kim HJ, Song GG, Jung JH. Intra-articular injection of stigmasterol-loaded nanoparticles reduce pain and inhibit the inflammation and joint destruction in osteoarthritis rat model: A pilot study. Drug Deliv Transl Res 2024; 14:1969-1981. [PMID: 38200400 DOI: 10.1007/s13346-023-01501-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/15/2023] [Indexed: 01/12/2024]
Abstract
Stigmasterol, a plant-derived sterol, sharing structural similarity with cholesterol, has demonstrated anti-osteoarthritis (OA) properties, attributed to its antioxidant and anti-inflammatory capabilities. Given that OA often arises in weight bearing or overused joints, prolonged localized treatment effectively targets inflammatory aspects of the disease. This research explored the impact of stigmasterol-loaded nanoparticles delivered via intra-articular injections in an OA rat model. Employing mesoporous silica nanomaterials (MSNs) combined with β-cyclodextrin (β-CD) as a vehicle, stigmasterol was loaded in conjunction with tannic acid, forming stigmasterol/β-CD-MSNs to facilitate a sustained stigmasterol release. The study employed RAW 264.7 cells to examine the in vitro cytotoxicity and anti-inflammatory effect of stigmasterol/β-CD-MSNs. For in vivo experimentation, we used healthy control rats and monosodium iodoacetate (MIA)-induced OA rats, separated into five groups, varying the injection substances. In vitro findings indicated that stigmasterol/β-CD-MSNs suppressed the mRNA expression of key pro-inflammatory mediators such as interleukin-6, tumor necrosis factor-α, and matrix metalloproteinase-3 in a dose-dependent manner. In vivo experiments revealed a substantial decrease in the mRNA levels of pro-inflammatory factors in the stigmasterol(50 µg)/β-CD-MSN group compared to the others. Macroscopic, radiographic, and histological evaluations established that intra-articular injections of stigmasterol/β-CD-MSNs inhibited cartilage degeneration and subchondral bone deterioration. Therefore, in a chemically induced OA rat model, intra-articular stigmasterol delivery was associated with reduction in both local and systemic inflammatory responses, alongside a slowdown in joint degradation and arthritic progression.
Collapse
Affiliation(s)
- Ji Hyun Lim
- Korea University College of Medicine, Seoul, Republic of Korea
| | - Sung Eun Kim
- Department of Orthopedic Surgery and Nano-Based Disease Control Institute, Korea University Guro Hospital, Seoul, Republic of Korea
| | - Hak-Jun Kim
- Korea University College of Medicine, Seoul, Republic of Korea
- Department of Orthopedic Surgery and Nano-Based Disease Control Institute, Korea University Guro Hospital, Seoul, Republic of Korea
| | - Gwan Gyu Song
- Korea University College of Medicine, Seoul, Republic of Korea
- Division of Rheumatology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea
| | - Jae Hyun Jung
- Korea University College of Medicine, Seoul, Republic of Korea.
- Division of Rheumatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
| |
Collapse
|
2
|
Farzan M, Roth R, Schoelkopf J, Huwyler J, Puchkov M. The processes behind drug loading and release in porous drug delivery systems. Eur J Pharm Biopharm 2023:S0939-6411(23)00141-8. [PMID: 37230292 DOI: 10.1016/j.ejpb.2023.05.019] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Revised: 05/07/2023] [Accepted: 05/22/2023] [Indexed: 05/27/2023]
Abstract
Porous materials are ubiquitous and exhibit properties suitable for depositing therapeutic compounds. Drug loading in porous materials can protect the drug, control its release rate, and improve its solubility. However, to achieve such outcomes from porous delivery systems, effective incorporation of the drug in the internal porosity of the carrier must be guaranteed. Mechanistic knowledge of the factors influencing drug loading and release from porous carriers allows rational design of formulations by selecting a suitable carrier for each application. Much of this knowledge exists in research areas other than drug delivery. Thus, a comprehensive overview of this topic from the drug delivery aspect is warranted. This review aims to identify the loading processes and carrier characteristics influencing the drug delivery outcome with porous materials. Additionally, the kinetics of drug release from porous materials are elucidated, and the common approaches to mathematical modeling of these processes are outlined.
Collapse
Affiliation(s)
- Maryam Farzan
- Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
| | - Roger Roth
- Fundamental Research, Omya International AG, Froschackerstrasse 6, CH-4622 Egerkingen, Switzerland
| | - Joachim Schoelkopf
- Fundamental Research, Omya International AG, Froschackerstrasse 6, CH-4622 Egerkingen, Switzerland
| | - Jörg Huwyler
- Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
| | - Maxim Puchkov
- Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, CH-4056 Basel, Switzerland
| |
Collapse
|
3
|
Abbas HS, Abd-elhakeem MM, Abd El Galil RM, Reyad OA, Mohamed HA, Ismail SES, Nabil MA. Natural Immunomodulators Treat the Cytokine Storm in SARS-CoV-2. Adv Pharm Bull 2023; 13:79-87. [PMID: 36721816 PMCID: PMC9871270 DOI: 10.34172/apb.2023.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Revised: 08/18/2021] [Accepted: 09/27/2021] [Indexed: 02/03/2023] Open
Abstract
Recently, the world has been dealing with a destructive global pandemic Coronavirus disease 2019 (COVID-19) infection, since 2020; there were millions of infections and hundreds of thousands of deaths worldwide. With sequencing generations of the virus, around 60% are expected to become infected during the pandemic. Unfortunately, no drug or vaccine has been approved because no real evidence from clinical trials in treatment was reached. According to current thinking, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mortality is caused by a cytokine storm syndrome in patients with hyper-inflammatory conditions, resulting in acute respiratory distress and finally death. In this review, we discuss the various types of natural immune-modulatory agents and their role in the management of SARS-CoV-2, and cytokine storm syndrome. For example, Polyphenols as natural products can block the binding of SARS-CoV-2 spike protein to host cell receptor ACE2, stop viral entry into the host cell and block viral RNA replication. Also, saikosaponins (A, B2, C, and D), triterpene glycosides, which are isolated from medicinal plants exert antiviral action against HCoV-22E9, and Houttuynia cordata water extract has antiviral effects on SARS-CoV. Moreover, eucalyptus oil has promising potential for COVID-19 prevention and treatment. There is an urgent need for research to improve the function of the human immune system all over the world. As a result, actions for better understanding and improving the human immune system are critical steps toward mitigating risks and negative outcomes. These approaches will be strongly recommended for future emerging viruses and pathogens.
Collapse
Affiliation(s)
- Heba Salah Abbas
- Microbiology Department, National Organization for Drug Control and Research(NODCAR), Egyptian Drug Authority, Giza, Egypt.,Corresponding Author: Heba Salah Abbas,
| | | | | | | | - Heba Ahmed Mohamed
- Master Student, Microbiology, Faculty of Science, Suez University, Egypt
| | | | - Manal Ahmed Nabil
- Department of Immunology & Allergy, Medical Research Institute, Alexandria University, Alexandria, Egypt
| |
Collapse
|
4
|
Zou Y, Huang B, Cao L, Deng Y, Su J. Tailored Mesoporous Inorganic Biomaterials: Assembly, Functionalization, and Drug Delivery Engineering. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2021; 33:e2005215. [PMID: 33251635 DOI: 10.1002/adma.202005215] [Citation(s) in RCA: 73] [Impact Index Per Article: 24.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 08/18/2020] [Indexed: 05/06/2023]
Abstract
Infectious or immune diseases have caused serious threat to human health due to their complexity and specificity, and emerging drug delivery systems (DDSs) have evolved into the most promising therapeutic strategy for drug-targeted therapy. Various mesoporous biomaterials are exploited and applied as efficient nanocarriers to loading drugs by virtue of their large surface area, high porosity, and prominent biocompatibility. Nanosized mesoporous nanocarriers show great potential in biomedical research, and it has become the research hotspot in the interdisciplinary field. Herein, recent progress and assembly mechanisms on mesoporous inorganic biomaterials (e.g., silica, carbon, metal oxide) are summarized systematically, and typical functionalization methods (i.e., hybridization, polymerization, and doping) for nanocarriers are also discussed in depth. Particularly, structure-activity relationship and the effect of physicochemical parameters of mesoporous biomaterials, including morphologies (e.g., hollow, core-shell), pore textures (e.g., pore size, pore volume), and surface features (e.g., roughness and hydrophilic/hydrophobic) in DDS application are overviewed and elucidated in detail. As one of the important development directions, advanced stimuli-responsive DDSs (e.g., pH, temperature, redox, ultrasound, light, magnetic field) are highlighted. Finally, the prospect of mesoporous biomaterials in disease therapeutics is stated, and it will open a new spring for the development of mesoporous nanocarriers.
Collapse
Affiliation(s)
- Yidong Zou
- Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China
| | - Biaotong Huang
- Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China
| | - Liehu Cao
- Department of Orthopedics, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, 200433, China
- Department of Orthopedics Trauma, Shanghai Luodian Hospital, Baoshan District, Shanghai, 201908, China
| | - Yonghui Deng
- Department of Chemistry, State Key Laboratory of Molecular Engineering of Polymers, Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, 200433, China
- State Key Lab of Transducer Technology, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai, 200050, China
| | - Jiacan Su
- Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China
- Department of Orthopedics, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, 200433, China
| |
Collapse
|
5
|
Noh SH, Jo HS, Choi S, Song HG, Kim HJ, Kim KN, Kim SE, Park K. Lactoferrin-Anchored Tannylated Mesoporous Silica Nanomaterials for Enhanced Osteo-Differentiation Ability. Pharmaceutics 2020; 13:pharmaceutics13010030. [PMID: 33375294 PMCID: PMC7823981 DOI: 10.3390/pharmaceutics13010030] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Revised: 12/23/2020] [Accepted: 12/24/2020] [Indexed: 01/28/2023] Open
Abstract
In the present study, we created lactoferrin-anchored mesoporous silica nanomaterials with absorbed tannic acid (LF/TA-MSNs) and evaluated the effect of these LF/TA-MSNs on the in vitro osteo-differentiation ability of adipose-derived stem cells (ADSCs) by testing alkaline phosphatase (ALP) level, calcium accumulation, and expression of osteo-differentiation-specific genes, including osteocalcin (OCN) and osteopontin (OPN). Both bare MSNs and LF/TA-MSNs exhibited round nano-particle structures. The LF/TA-MSNs demonstrated prolonged LF release for up to 28 days. Treatment of ADSCs with LF (50 μg)/TA-MSNs resulted in markedly higher ALP level and calcium accumulation compared to treatment with LF (10 μg)/TA-MSNs or bare MSNs. Furthermore, LF (50 μg)/TA-MSNs remarkably increased mRNA levels of osteo-differentiation-specific genes, including OCN and OPN, compared to MSNs or LF (10 μg)/TA-MSNs. Together, these data suggest that the ability of LF/TA-MSNs to enhance osteo-differentiation of ADSCs make them a possible nanovehicle for bone healing and bone regeneration in patients with bone defect or disease.
Collapse
Affiliation(s)
- Sung Hyun Noh
- Department of Neurosurgery, National Health Insurance Service Ilsan Hospital, #100, Ilsan-ro, Ilsan-donggu, Gyeonggi-do, Goyang-si 10444, Korea;
| | - Han-Saem Jo
- Department of Systems Biotechnology, Chung-Ang University, Gyeonggi-do, Anseong-si 17546, Korea; (H.-S.J.); (H.G.S.)
| | - Somang Choi
- Department of Orthopedic Surgery and Rare Diseases Institute, Korea University Guro Hospital, #148, Gurodong-ro, Guro-gu, Seoul 08308, Korea; (S.C.); (H.-J.K.)
| | - Hee Gyeong Song
- Department of Systems Biotechnology, Chung-Ang University, Gyeonggi-do, Anseong-si 17546, Korea; (H.-S.J.); (H.G.S.)
| | - Hak-Jun Kim
- Department of Orthopedic Surgery and Rare Diseases Institute, Korea University Guro Hospital, #148, Gurodong-ro, Guro-gu, Seoul 08308, Korea; (S.C.); (H.-J.K.)
| | - Keung Nyun Kim
- Department of Neurosurgery, Spine and Spinal Cord Institute, Severance Hospital, Yonsei University College of Medicine, #50, Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
- Correspondence: (K.N.K.); (S.E.K.); (K.P.); Tel.: +82-2-2228-2161 (K.N.K.); +82-2-2626-1999 (S.E.K.); +82-31-670-3357 (K.P.)
| | - Sung Eun Kim
- Department of Orthopedic Surgery and Rare Diseases Institute, Korea University Guro Hospital, #148, Gurodong-ro, Guro-gu, Seoul 08308, Korea; (S.C.); (H.-J.K.)
- Correspondence: (K.N.K.); (S.E.K.); (K.P.); Tel.: +82-2-2228-2161 (K.N.K.); +82-2-2626-1999 (S.E.K.); +82-31-670-3357 (K.P.)
| | - Kyeongsoon Park
- Department of Systems Biotechnology, Chung-Ang University, Gyeonggi-do, Anseong-si 17546, Korea; (H.-S.J.); (H.G.S.)
- Correspondence: (K.N.K.); (S.E.K.); (K.P.); Tel.: +82-2-2228-2161 (K.N.K.); +82-2-2626-1999 (S.E.K.); +82-31-670-3357 (K.P.)
| |
Collapse
|
6
|
Porgham Daryasari M, Dusti Telgerd M, Hossein Karami M, Zandi-Karimi A, Akbarijavar H, Khoobi M, Seyedjafari E, Birhanu G, Khosravian P, SadatMahdavi F. Poly-l-lactic acid scaffold incorporated chitosan-coated mesoporous silica nanoparticles as pH-sensitive composite for enhanced osteogenic differentiation of human adipose tissue stem cells by dexamethasone delivery. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2020; 47:4020-4029. [PMID: 31595797 DOI: 10.1080/21691401.2019.1658594] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Nowadays, the development of drug-loaded electrospun organic-inorganic composite scaffolds for tissue engineering application is an attractive approach. In this study, a composite scaffold of Poly-l-lactic acid (PLLA) incorporated dexamethasone (Dexa) loaded Mesoporous Silica Nanoparticles (MSN) coated with Chitosan (CS) were fabricated by electrospinning for bone tissue engineering application. The MSN was prepared by precipitation method. After that, Dexamethasone (Dexa) was loaded into MSNs (MSN-Dexa). In the following, CS was coated over the prepared nanoparticles to form MSN-Dexa@CS and then, were mixed to PLLA solution to form MSN-Dexa@CS/PLLA composite for electrospinning. The surface morphology, hydrophilicity, tensile strength and the bioactivity of the scaffolds were characterized. The osteogenic proliferation and differentiation potential were evaluated by MTT assay and by measuring the basic osteogenic markers: the activity of the enzyme alkaline phosphatase and the level of calcium deposition. The composite scaffolds prepared here have conductive surface property and have a better osteogenic potential than pure PLLA scaffolds. Hence, the controlled release of nanoparticle containing Dexa from composite scaffold supported the osteogenesis and made the composite scaffolds ideal candidates for bone tissue engineering application and pH-sensitive delivery of drugs at the site of implantation in tissue regeneration.
Collapse
Affiliation(s)
- Mohammad Porgham Daryasari
- Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran , Iran.,Biomaterials Group, the Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences , Tehran , Iran
| | - Mehdi Dusti Telgerd
- Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran , Iran
| | | | - Ali Zandi-Karimi
- Department of Biotechnology, College of Science, University of Tehran , Tehran , Iran
| | - Hamid Akbarijavar
- Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran , Iran
| | - Mehdi Khoobi
- Biomaterials Group, the Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences , Tehran , Iran.,Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center (MBRC), Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran , Iran
| | - Ehsan Seyedjafari
- Department of Biotechnology, College of Science, University of Tehran , Tehran , Iran
| | - Gebremariam Birhanu
- Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, International campus (TUMS-IC) , Tehran , Iran.,School of Pharmacy, College of Health Sciences, Addis Ababa University , Addis Ababa , Ethiopia
| | - Pegah Khosravian
- Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences , Shahrekord , Iran
| | - Fatemeh SadatMahdavi
- Department of Animal and Poultry Science, College of Aburaihan, University of Tehran , Pakdasht, Tehran , Iran
| |
Collapse
|
7
|
Mitra S, Kumar R, Roy P, Basu S, Barik S, Goswami A. Naturally Occurring and Synthetic Mesoporous Nanosilica: Multimodal Applications in Frontier Areas of Science. INTERNATIONAL JOURNAL OF NANOSCIENCE 2019. [DOI: 10.1142/s0219581x18500278] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Mesoporous silica nanoparticles (MSNs) have gained attention worldwide due to their structural versatility for diverse applications in a number of frontier areas of sciences. The intrinsic chemical, textural and structural features of MSNs allow fabricating versatile multifunctional nanosystems. The present review provides an overview of the research progress in artificial and biological production of MSNs, their properties and various applications in cutting edge areas of sciences.
Collapse
Affiliation(s)
- Sutanuka Mitra
- Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Kolkata 700 108, India
| | - Rajesh Kumar
- Division of Agricultural Chemicals, ICAR-Indian Agricultural Research Institute, Pusa Campus, New Delhi 110 012, India
| | - Pradip Roy
- Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Kolkata 700 108, India
| | - Satakshi Basu
- Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Kolkata 700 108, India
| | - Samarendra Barik
- Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Kolkata 700 108, India
| | - Arunava Goswami
- Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Kolkata 700 108, India
| |
Collapse
|
8
|
Bremmell KE, Prestidge CA. Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges. Drug Dev Ind Pharm 2018; 45:349-358. [PMID: 30411991 DOI: 10.1080/03639045.2018.1542709] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Porous silica-based drug delivery systems have shown considerable promise for improving the oral delivery of poorly water-soluble drugs. More specifically, micro- and meso-porous silica carriers have high surface areas with associated ability to physically adsorb high-drug loads in a molecular or amorphous form; this allows molecular state drug release in aqueous gastrointestinal environments, potential for supersaturation, and hence facilitates enhanced absorption and increased bioavailability. This review focuses primarily on the ability of porous silica materials to modulate in vitro drug release and enhance in vivo biopharmaceutical performance. The key considerations identified and addressed are the physicochemical properties of the porous silica materials (e.g. the particle and pore size, shape, and surface chemistry), drug specific properties (e.g. pKa, solubility, and nature of interactions with the silica carrier), potential for both immediate and controlled release, drug release mechanisms, potential for surface functionalization and inclusion of precipitation inhibitors, and importance of utilizing relevant and effective in vitro dissolution methods with discriminating dissolution media that provides guidance for in vivo outcomes (i.e. IVIVC).
Collapse
Affiliation(s)
- Kristen E Bremmell
- a School of Pharmacy and Medical Sciences , University of South Australia , Adelaide , Australia
| | - Clive A Prestidge
- a School of Pharmacy and Medical Sciences , University of South Australia , Adelaide , Australia.,b ARC Centre of Excellence in Convergent Bio-Nano Science and Technology , University of South Australia , South Australia , Australia
| |
Collapse
|
9
|
Bouchal R, Daurat M, Gary-Bobo M, Da Silva A, Lesaffre L, Aggad D, Godefroy A, Dieudonné P, Charnay C, Durand JO, Hesemann P. Biocompatible Periodic Mesoporous Ionosilica Nanoparticles with Ammonium Walls: Application to Drug Delivery. ACS APPLIED MATERIALS & INTERFACES 2017; 9:32018-32025. [PMID: 28845972 DOI: 10.1021/acsami.7b07264] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Periodic mesoporous ionosilica nanoparticles with ammonium walls were synthesized exclusively from a trisilylated ammonium precursor. The nanoparticles display a uniform particle size, together with a high specific surface area and an ordered hexagonal pore architecture. Completely biocompatible in vitro and in vivo, the nanoparticles are efficiently endocytosed by RAW 264.7 macrophages and used as carrier vehicles for anionic drugs. Diclofenac-loaded ionosilica nanoparticles are very efficient in inhibiting lipopolysaccharides-induced inflammation.
Collapse
Affiliation(s)
- Roza Bouchal
- Institut Charles Gerhardt de Montpellier, UMR 5253 CNRS-UM-ENSCM, Université de Montpellier , Place Eugène Bataillon, 34095 Montpellier Cedex 05, France
| | - Morgane Daurat
- Faculté de Pharmacie, Institut de Biomolécules Max Mousseron, UMR 5247 CNRS-UM , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
- NanoMedSyn , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
| | - Magali Gary-Bobo
- Faculté de Pharmacie, Institut de Biomolécules Max Mousseron, UMR 5247 CNRS-UM , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
| | - Afitz Da Silva
- Faculté de Pharmacie, Institut de Biomolécules Max Mousseron, UMR 5247 CNRS-UM , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
- NanoMedSyn , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
| | - Leïla Lesaffre
- Faculté de Pharmacie, Institut de Biomolécules Max Mousseron, UMR 5247 CNRS-UM , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
| | - Dina Aggad
- Faculté de Pharmacie, Institut de Biomolécules Max Mousseron, UMR 5247 CNRS-UM , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
| | - Anastasia Godefroy
- Faculté de Pharmacie, Institut de Biomolécules Max Mousseron, UMR 5247 CNRS-UM , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
- NanoMedSyn , 15 Avenue Charles Flahault, 34093 Montpellier Cedex 05, France
| | - Philippe Dieudonné
- Laboratoire Charles Coulomb, UMR CNRS 5521, Université de Montpellier , Place Eugène Bataillon, F-34095 Montpellier Cedex, France
| | - Clarence Charnay
- Institut Charles Gerhardt de Montpellier, UMR 5253 CNRS-UM-ENSCM, Université de Montpellier , Place Eugène Bataillon, 34095 Montpellier Cedex 05, France
| | - Jean-Olivier Durand
- Institut Charles Gerhardt de Montpellier, UMR 5253 CNRS-UM-ENSCM, Université de Montpellier , Place Eugène Bataillon, 34095 Montpellier Cedex 05, France
| | - Peter Hesemann
- Institut Charles Gerhardt de Montpellier, UMR 5253 CNRS-UM-ENSCM, Université de Montpellier , Place Eugène Bataillon, 34095 Montpellier Cedex 05, France
| |
Collapse
|
10
|
B. Shekhawat P, B. Pokharkar V. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm Sin B 2017; 7:260-280. [PMID: 28540164 PMCID: PMC5430883 DOI: 10.1016/j.apsb.2016.09.005] [Citation(s) in RCA: 93] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Revised: 09/06/2016] [Accepted: 09/21/2016] [Indexed: 11/10/2022] Open
Abstract
Oral drug absorption is a process influenced by the physicochemical and biopharmaceutical properties of the drug and its inter-relationship with the gastrointestinal tract. Drug solubility, dissolution and permeability across intestinal barrier are the key parameters controlling absorption. This review provides an overview of the factors that affect drug absorption and the classification of a drug on the basis of solubility and permeability. The biopharmaceutical classification system (BCS) was introduced in early 90׳s and is a regulatory tool used to predict bioavailability problems associated with a new entity, thereby helping in the development of a drug product. Strategies to combat solubility and permeability issues are also discussed.
Collapse
Key Words
- ABC, ATP-binding cassette
- AP, absorption potential
- API, active pharmaceutical ingredient
- ATP, adenosine triphosphate
- AZT, azidothymidine
- BA/BE, bioavailability/bioequivalence
- BCRP, breast cancer resistance protein
- BCS
- BCS, biopharmaceutical classification system
- BDDS, biopharmaceutical drug disposition system
- BSP, bromosulfophthalein
- CD, cyclodextrin
- CDER, Centre for Drug Evaluation and Research
- CNT, Na+-dependent concentrative transporter
- CNT, concentrative nucleoside transporter
- CYP, cytochrome P450
- D:S, dose:solubility
- E217G, estradiol 17β-glucuronide
- EMEA, European Medicines Agency
- ENT, equilibrative nucleoside transporter
- FATP, fatty acid transporter protein
- FDA, U.S. Food and Drug Administration
- FIP, International Pharmaceutical Federation
- FaSSIF, fasted state simulated intestinal fluid
- Factors affecting absorption
- FeSSIF, fed state simulated intestinal fluid
- Formulation strategies
- GIS, gastrointestinal simulator
- GIT, gastrointestinal tract
- GITA, gastrointestinal transit and absorption
- GLUT, sodium-independent facilitated diffusion transporter
- GRAS, generally recognized as safe
- HIV, human immunodeficiency disease
- HPC-SL, LBDDS, lipid based drug delivery system
- HUGO, Human Genome Organization
- ICH, International Council of Harmonization
- IDR, intrinsic dissolution rate
- IR, immediate release
- ISBT, sodium dependent bile salt transporter
- MCT, monocarboxylate transporter
- MPP, 1-methyl-4-phenylpyridinium
- MRP, multidrug resistance associated protein
- NLC, nanostructured lipid carrier
- NME, new molecular entity
- NTCP, sodium-dependent taurocholate co-transporting polypeptide
- OAT, organic anion transporter
- OATP, organic anion transporting polypeptide
- OCT, organic cationic transporter
- OCTN, organic cationic/carnitine transporter
- OMM, ordered mesoporous material
- P-gp, P-glycoprotein
- PAH, p-aminohippurate
- PAMPA, parallel artificial membrane permeability assay
- PEG, polyethylene glycol
- PEI, polyethyleneimine
- PEPT, peptide transporter
- PGA, polyglycolic acid
- PLA, poly(lactic acid)
- PLGA, poly-d,l-lactide-co-glycoside
- PMAT, plasma membrane monoamine transport
- PSA, polar surface area
- PVDF, polyvinylidene difluoride
- Papp, apparent permeability
- Peff, effective permeability
- Permeability
- Psi, porous silicon
- RFC, reduced folate transporter
- SDS, sodium dodecyl sulphate
- SGLT, sodium dependent secondary active transporter
- SIF, simulated intestinal fluid
- SLC, solute carrier
- SLCO, solute carrier organic anion
- SLN, solid lipid nanoparticles
- SMVT, sodium dependent multivitamin transporter
- SPIP, single pass intestinal perfusion
- SUPAC, scale-up and post approval changes
- SVCT, sodium-dependent vitamin C transporter
- Solubility
- TEOS, tetraethylortho silicate
- UWL, unstirred water layer
- VDAD, volume to dissolve applied dose
- WHO, World Health Organization
- pMMA, polymethyl methacrylate
- vit. E TPGS, vitamin E tocopherol polyethylene glycol succinate
Collapse
|
11
|
Oral hesperidin—Amorphization and improved dissolution properties by controlled loading onto porous silica. Int J Pharm 2017; 518:253-263. [DOI: 10.1016/j.ijpharm.2016.11.005] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2016] [Revised: 10/26/2016] [Accepted: 11/02/2016] [Indexed: 11/19/2022]
|
12
|
Cao L, Weng W, Chen X, Zhang J, Zhou Q, Cui J, Wang L, Shin JW, Su J. Effects of mesoporous calcium magnesium silicate on setting time, compressive strength, apatite formation, degradability and cell behavior to magnesium phosphate based bone cements. RSC Adv 2017. [DOI: 10.1039/c6ra25503e] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Mesoporous calcium magnesium silicate was doped into magnesium phosphate to fabricate magnesium phosphate based composite cements (MBC).
Collapse
Affiliation(s)
- Liehu Cao
- Department of Orthopaedics Trauma
- Changhai Hospital
- Second Military Medical University
- Shanghai 200433
- China
| | - Weizong Weng
- Department of Orthopaedics Trauma
- Changhai Hospital
- Second Military Medical University
- Shanghai 200433
- China
| | - Xiao Chen
- Department of Orthopaedics Trauma
- Changhai Hospital
- Second Military Medical University
- Shanghai 200433
- China
| | - Jun Zhang
- Department of Orthopaedics Trauma
- Changhai Hospital
- Second Military Medical University
- Shanghai 200433
- China
| | - Qirong Zhou
- Department of Orthopaedics Trauma
- Changhai Hospital
- Second Military Medical University
- Shanghai 200433
- China
| | - Jin Cui
- Department of Orthopaedics Trauma
- Changhai Hospital
- Second Military Medical University
- Shanghai 200433
- China
| | - Lin Wang
- Department of Orthopaedics Trauma
- Changhai Hospital
- Second Military Medical University
- Shanghai 200433
- China
| | - Jung-Woog Shin
- Department of Biomedical Engineering
- Inje University
- Gimhae
- Republic of Korea
| | - Jiacan Su
- Department of Orthopaedics Trauma
- Changhai Hospital
- Second Military Medical University
- Shanghai 200433
- China
| |
Collapse
|
13
|
Cicco SR, Vona D, Gristina R, Sardella E, Ragni R, Lo Presti M, Farinola GM. Biosilica from Living Diatoms: Investigations on Biocompatibility of Bare and Chemically Modified Thalassiosira weissflogii Silica Shells. Bioengineering (Basel) 2016; 3:E35. [PMID: 28952597 PMCID: PMC5597278 DOI: 10.3390/bioengineering3040035] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2016] [Revised: 12/02/2016] [Accepted: 12/07/2016] [Indexed: 12/20/2022] Open
Abstract
In the past decade, mesoporous silica nanoparticles (MSNs) with a large surface area and pore volume have attracted considerable attention for their application in drug delivery and biomedicine. Here we propose biosilica from diatoms as an alternative source of mesoporous materials in the field of multifunctional supports for cell growth: the biosilica surfaces were chemically modified by traditional silanization methods resulting in diatom silica microparticles functionalized with 3-mercaptopropyl-trimethoxysilane (MPTMS) and 3-aminopropyl-triethoxysilane (APTES). Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy analyses revealed that the -SH or -NH₂ were successfully grafted onto the biosilica surface. The relationship among the type of functional groups and the cell viability was established as well as the interaction of the cells with the nanoporosity of frustules. These results show that diatom microparticles are promising natural biomaterials suitable for cell growth, and that the surfaces, owing to the mercapto groups, exhibit good biocompatibility.
Collapse
Affiliation(s)
- Stefania Roberta Cicco
- Italian National Council for Research-Institute for the Chemistry of OrganoMetallic Compounds (CNR-ICCOM)-Bari, Bari 70126, Italy.
| | - Danilo Vona
- Department of Chemistry, Università degli Studi di Bari Aldo Moro, Bari 70121, Italy.
| | | | | | - Roberta Ragni
- Department of Chemistry, Università degli Studi di Bari Aldo Moro, Bari 70121, Italy.
| | - Marco Lo Presti
- Department of Chemistry, Università degli Studi di Bari Aldo Moro, Bari 70121, Italy.
| | | |
Collapse
|
14
|
Wei Q, Keck CM, Müller RH. Preparation and tableting of long-term stable amorphous rutin using porous silica. Eur J Pharm Biopharm 2016; 113:97-107. [PMID: 27847275 DOI: 10.1016/j.ejpb.2016.11.009] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2016] [Revised: 10/27/2016] [Accepted: 11/03/2016] [Indexed: 11/16/2022]
Abstract
Amorphous state of drugs increases the oral bioavailability, but typically faces physical stability problems. Amorphous rutin was generated and physically stabilized by encapsulating inside mesopores of porous AEROPERL® 300 Pharma and named as rutin CapsMorph® in this study. AEROPERL® 300 Pharma was loaded with rutin dissolved in DMSO containing Tween 80, and subsequently the solvent evaporated (wetness impregnation method). The loading process was monitored by light microscopy and scanning electron microscopy (SEM). X-ray diffraction (XRD) and differential scanning calorimetry (DSC) were used to confirm the amorphous state in AEROPERL® 300 Pharma. A loading of 20% of the rutin-AEROPERL® 300 Pharma mixture was obtained. The amorphous state proved to be stable over 2years of storage at room temperature. Due to the amorphous state and the nanosize of the rutin in the mesopores, the kinetic saturation solubility increased to about 4mg/ml (water, 0.1MHCl, pH 6.8PBS) compared to the maximum observed thermodynamic equilibrium solubility of rutin raw drug powder of only 74.48±1.42μg/ml in pH 6.8PBS (=increase by factor about 54). The dissolution velocity also increased distinctly, e.g. about 96.1% of rutin dissolution from CapsMorph® powder in water within 5min compared to less than 40% of raw drug powder after 3h. Tablets were produced with rutin CapsMorph®, raw drug powder and their dissolution velocity compared to a marketed product. About 83.0-95.6% were released from the rutin CapsMorph® tablet within 5min, compared to 42.7-52.5% from the marketed tablet after 3h (water, 0.1MHCl, pH 6.8PBS). After dissolution the supersaturation level of rutin CapsMorph® remained over about 2h, then solubility slowly reduced, but remained after 48h still multifold above the thermodynamic rutin solubility. This should be sufficient for many poorly soluble drugs to achieve a sufficient bioavailability. For optimal exploitation of the supersaturation, a multiple step release system could be used, e.g. release of CapsMorph® particles every 2-3h.
Collapse
Affiliation(s)
- Qionghua Wei
- Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics & NutriCosmetics, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany
| | | | - Rainer H Müller
- Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics & NutriCosmetics, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany.
| |
Collapse
|
15
|
Benedetto G, Vestal CG, Richardson C. Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment. Target Oncol 2016; 10:467-85. [PMID: 25989948 DOI: 10.1007/s11523-015-0371-z] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Conventional delivery of chemotherapeutic agents leads to multiple systemic side effects and toxicity, limiting the doses that can be used. The development of targeted therapies to selectively deliver anti-cancer agents to tumor cells without damaging neighboring unaffected cells would lead to higher effective local doses and improved response rates. Aptamers are single-stranded oligonucleotides that bind to target molecules with both high affinity and high specificity. The high specificity exhibited by aptamers promotes localization and uptake by specific cell populations, such as tumor cells, and their conjugation to anti-cancer drugs has been explored for targeted therapy. Advancements in the development of polymeric nanoparticles allow anti-cancer drugs to be encapsulated in protective nonreactive shells for controlled drug delivery with reduced toxicity. The conjugation of aptamers to nanoparticle-based therapeutics may further enhance direct targeting and personalized medicine. Here we present how the combinatorial use of aptamer and nanoparticle technologies has the potential to develop "smart bombs" for targeted cancer treatment, highlighting recent pre-clinical studies demonstrating efficacy for the direct targeting to particular tumor cell populations. However, despite these pre-clinical promising results, there has been little progress in moving this technology to the bedside.
Collapse
Affiliation(s)
- Gregory Benedetto
- Department of Biological Sciences, UNC Charlotte, 1902 University City Blvd., Woodward Hall Room 386B, Charlotte, NC, 28223, USA.
| | - C Greer Vestal
- Department of Biological Sciences, UNC Charlotte, 1902 University City Blvd., Woodward Hall Room 386B, Charlotte, NC, 28223, USA.
| | - Christine Richardson
- Department of Biological Sciences, UNC Charlotte, 1902 University City Blvd., Woodward Hall Room 386B, Charlotte, NC, 28223, USA.
| |
Collapse
|
16
|
A Smart pH-responsive Nano-Carrier as a Drug Delivery System: A hybrid system comprised of mesoporous nanosilica MCM-41 (as a nano-container) & a pH-sensitive polymer (as smart reversible gatekeepers): Preparation, characterization and in vitro release studies of an anti-cancer drug. Eur J Pharm Sci 2016; 93:64-73. [DOI: 10.1016/j.ejps.2016.08.005] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2016] [Revised: 07/09/2016] [Accepted: 08/02/2016] [Indexed: 01/27/2023]
|
17
|
Sun R, Wang W, Wen Y, Zhang X. Recent Advance on Mesoporous Silica Nanoparticles-Based Controlled Release System: Intelligent Switches Open up New Horizon. NANOMATERIALS (BASEL, SWITZERLAND) 2015; 5:2019-2053. [PMID: 28347110 PMCID: PMC5304765 DOI: 10.3390/nano5042019] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/30/2015] [Revised: 10/25/2015] [Accepted: 10/28/2015] [Indexed: 12/18/2022]
Abstract
Mesoporous silica nanoparticle (MSN)-based intelligent transport systems have attracted many researchers' attention due to the characteristics of uniform pore and particle size distribution, good biocompatibility, high surface area, and versatile functionalization, which have led to their widespread application in diverse areas. In the past two decades, many kinds of smart controlled release systems were prepared with the development of brilliant nano-switches. This article reviews and discusses the advantages of MSN-based controlled release systems. Meanwhile, the switching mechanisms based on different types of stimulus response are systematically analyzed and summarized. Additionally, the application fields of these devices are further discussed. Obviously, the recent evolution of smart nano-switches promoted the upgrading of the controlled release system from the simple "separated" switch to the reversible, multifunctional, complicated logical switches and selective switches. Especially the free-blockage switches, which are based on hydrophobic/hydrophilic conversion, have been proposed and designed in the last two years. The prospects and directions of this research field are also briefly addressed, which could be better used to promote the further development of this field to meet the needs of mankind.
Collapse
Affiliation(s)
- Ruijuan Sun
- Research Center for Bioengineering & Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China.
| | - Wenqian Wang
- Research Center for Bioengineering & Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China.
| | - Yongqiang Wen
- Research Center for Bioengineering & Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China.
| | - Xueji Zhang
- Research Center for Bioengineering & Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China.
| |
Collapse
|
18
|
Li X, Zhang Q, Ahmad Z, Huang J, Ren Z, Weng W, Han G, Mao C. Near-infrared luminescent CaTiO 3:Nd 3+ nanofibers with tunable and trackable drug release kinetics. J Mater Chem B 2015; 3:7449-7456. [PMID: 27398215 PMCID: PMC4934121 DOI: 10.1039/c5tb01158b] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
750-850 nm (NIR I) and 1000-1400 nm (NIR II) in the near infrared (NIR) spectra are two windows of optical transparency for biological tissues with the latter capable of penetrating tissue deeper. Monitoring drug release from the drug carrier is still a daunting challenge in the field of nanomedicine. To overcome such a challenge, we propose to use porous Nd3+-doped CaTiO3 nanofibers, which can be excited by NIR I to emit NIR II light, to carry drugs to test the concept of monitoring drug release from the nanofibers by detecting the NIR II emission intensity. Towards this end, we first used electrospinning to prepare porous Nd3+-doped CaTiO3 nanofibers by adding micelle-forming surfactant Pluronic F127, followed by annealing to remove the organic component. After a model drug, ibuprofen, was loaded into the porous nanofibers, the drug release from the nanofibers into the phosphate buffered saline (PBS) solution was monitored by detecting the NIR II emission from the nanofibers. We found that the release of the drug molecules from the nanofibers into the PBS solution triggers the quenching of NIR II emission by the hydroxyl groups in the surrounding media. Consequently, more drug release corresponded to more reduction in the intensity of the NIR II emission, allowing us to monitor the drug release by simply detecting the intensity of NIR II from the nanofibers. In addition, we demonstrated that tuning the amount of micelle-forming surfactant Pluronic F127 enabled us to tune the porosity of the nanofibers and thus the drug release kinetics. This study suggests that Nd3+ doped CaTiO3 nanostructures can serve as a promising drug delivery platform with the potential to monitor drug release kinetics by detecting the tissue-penetrating NIR emission.
Collapse
Affiliation(s)
- Xiang Li
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China
| | - Qiuhong Zhang
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China
| | - Zeeshan Ahmad
- Leicester School of Pharmacy, De Montfort University, Leicester, LE1 9BH, UK
| | - Jie Huang
- Department of Mechanical Engineering, University College London, London, WC1E 7JE, UK
| | - Zhaohui Ren
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China
| | - Wenjian Weng
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China
| | - Gaorong Han
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China
| | - Chuanbin Mao
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310027, P. R. China
- Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma, 73019-5300, USA
| |
Collapse
|
19
|
Zhang Q, Li X, Ren Z, Han G, Mao C. Synthesis of CaTiO 3 Nanofibers with Controllable Drug-Release Kinetics. Eur J Inorg Chem 2015; 2015:4532-4538. [PMID: 27818612 PMCID: PMC5091301 DOI: 10.1002/ejic.201500737] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2015] [Indexed: 11/06/2022]
Abstract
Calcium titanate (CaTiO3) nanofibers with controlled microstructure were fabricated by a combination of sol-gel and electrospinning approaches. The fiber morphology has been found to rely significantly on the precursor composition. Altering the volume ratio of ethanol to acetic acid from 3.5 to 1.25 enables the morphology of the CaTiO3 nanofibers to be transformed from fibers with a circular cross section to curved ribbon-like structures. Ibuprofen (IBU) was used as a model drug to investigate the drug-loading capacity and drug-release profile of the nanofibers. It was found that the BET surface area and the pore volume decrease markedly with the utilization of F127 surfactant. The nanofibers synthesized without F127 surfactant present the highest drug-loading capacity and the most sustained release kinetics. This study suggests that calcium titanate nanofibers can offer a promising platform for localized drug delivery.
Collapse
Affiliation(s)
- Qiuhong Zhang
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou 310027, P. R. China
| | - Xiang Li
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou 310027, P. R. China
| | - Zhaohui Ren
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou 310027, P. R. China
| | - Gaorong Han
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou 310027, P. R. China
| | - Chuanbin Mao
- State Key Laboratory of Silicon Materials, School of Materials Science and Engineering, Zhejiang University, Hangzhou 310027, P. R. China
- Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019-5300, USA
| |
Collapse
|
20
|
Luo Z, Deng Y, Zhang R, Wang M, Bai Y, Zhao Q, Lyu Y, Wei J, Wei S. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering. Colloids Surf B Biointerfaces 2015; 131:73-82. [DOI: 10.1016/j.colsurfb.2015.04.043] [Citation(s) in RCA: 60] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2015] [Revised: 04/16/2015] [Accepted: 04/20/2015] [Indexed: 01/12/2023]
|
21
|
Shadjou N, Hasanzadeh M. Bone tissue engineering using silica-based mesoporous nanobiomaterials:Recent progress. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2015; 55:401-9. [PMID: 26117771 DOI: 10.1016/j.msec.2015.05.027] [Citation(s) in RCA: 79] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/27/2015] [Revised: 04/25/2015] [Accepted: 05/08/2015] [Indexed: 12/25/2022]
Abstract
Bone disorders are of significant concern due to increase in the median age of our population. It is in this context that tissue engineering has been emerging as a valid approach to the current therapies for bone regeneration/substitution. Tissue-engineered bone constructs have the potential to alleviate the demand arising from the shortage of suitable autograft and allograft materials for augmenting bone healing. Silica based mesostructured nanomaterials possessing pore sizes in the range 2-50 nm and surface reactive functionalities have elicited immense interest due to their exciting prospects in bone tissue engineering. In this review we describe application of silica-based mesoporous nanomaterials for bone tissue engineering. We summarize the preparation methods, the effect of mesopore templates and composition on the mesopore-structure characteristics, and different forms of these materials, including particles, fibers, spheres, scaffolds and composites. Also, the effect of structural and textural properties of mesoporous materials on development of new biomaterials for production of bone implants and bone cements was discussed. Also, application of different mesoporous materials on construction of manufacture 3-dimensional scaffolds for bone tissue engineering was discussed. It begins by giving the reader a brief background on tissue engineering, followed by a comprehensive description of all the relevant components of silica-based mesoporous biomaterials on bone tissue engineering, going from materials to scaffolds and from cells to tissue engineering strategies that will lead to "engineered" bone.
Collapse
Affiliation(s)
- Nasrin Shadjou
- Department of Nanochemistry, Nano Technology Research Center and Faculty of Chemistry, Urmia University, Urmia, Iran.
| | - Mohammad Hasanzadeh
- Department of Nanochemistry, Nano Technology Research Center and Faculty of Chemistry, Urmia University, Urmia, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz 51664, Iran.
| |
Collapse
|
22
|
Li C, Hou J, Huang Z, Zhao T, Xiao L, Gao G, Harnoode C, Dong A. Assessment of 2,2,6,6-tetramethyl-4-piperidinol-based amine N-halamine-labeled silica nanoparticles as potent antibiotics for deactivating bacteria. Colloids Surf B Biointerfaces 2015; 126:106-14. [DOI: 10.1016/j.colsurfb.2014.11.051] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2014] [Revised: 10/27/2014] [Accepted: 11/05/2014] [Indexed: 01/22/2023]
|
23
|
Sponchia G, Ambrosi E, Rizzolio F, Hadla M, Tedesco AD, Spena CR, Toffoli G, Riello P, Benedetti A. Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications. J Mater Chem B 2015; 3:7300-7306. [DOI: 10.1039/c5tb01424g] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
24
|
Pang J, Li X, Zhou G, Sun B, Wei Y. Fabrication of mesoporous silica nanospheres with radially oriented mesochannels by microemulsion templating for adsorption and controlled release of aspirin. RSC Adv 2015. [DOI: 10.1039/c4ra12291g] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The MSN spheres with narrow size distribution and radially oriented mesoporous channels were prepared using an O/W microemulsion system, consisting of CTAB (or PVP), ethanol, cyclohexane and water as template.
Collapse
Affiliation(s)
- Jinli Pang
- Key Laboratory of Fine Chemicals in Universities of Shandong
- School of Chemistry and Pharmaceutical Engineering
- Qilu University of Technology
- Jinan 250353
- People's Republic of China
| | - Xiuyan Li
- Key Laboratory of Fine Chemicals in Universities of Shandong
- School of Chemistry and Pharmaceutical Engineering
- Qilu University of Technology
- Jinan 250353
- People's Republic of China
| | - Guowei Zhou
- Key Laboratory of Fine Chemicals in Universities of Shandong
- School of Chemistry and Pharmaceutical Engineering
- Qilu University of Technology
- Jinan 250353
- People's Republic of China
| | - Bin Sun
- Key Laboratory of Fine Chemicals in Universities of Shandong
- School of Chemistry and Pharmaceutical Engineering
- Qilu University of Technology
- Jinan 250353
- People's Republic of China
| | - Yingqin Wei
- Key Laboratory of Fine Chemicals in Universities of Shandong
- School of Chemistry and Pharmaceutical Engineering
- Qilu University of Technology
- Jinan 250353
- People's Republic of China
| |
Collapse
|
25
|
In vitro degradability, bioactivity and cell responses to mesoporous magnesium silicate for the induction of bone regeneration. Colloids Surf B Biointerfaces 2014; 120:38-46. [DOI: 10.1016/j.colsurfb.2014.04.010] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2013] [Revised: 04/14/2014] [Accepted: 04/15/2014] [Indexed: 01/30/2023]
|
26
|
Bahrami Z, Badiei A, Atyabi F. Surface functionalization of SBA-15 nanorods for anticancer drug delivery. Chem Eng Res Des 2014. [DOI: 10.1016/j.cherd.2013.11.007] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
27
|
Effect of polyvinylpyrrolidone on mesoporous silica morphology and esterification of lauric acid with 1-butanol catalyzed by immobilized enzyme. J SOLID STATE CHEM 2014. [DOI: 10.1016/j.jssc.2014.03.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
28
|
Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release. J Colloid Interface Sci 2014; 421:6-13. [DOI: 10.1016/j.jcis.2014.01.034] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2013] [Revised: 01/22/2014] [Accepted: 01/24/2014] [Indexed: 11/23/2022]
|
29
|
Ag-silica composite nanotube with controlled wall structures for biomedical applications. Colloids Surf B Biointerfaces 2013; 111:693-8. [DOI: 10.1016/j.colsurfb.2013.07.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2013] [Revised: 07/02/2013] [Accepted: 07/03/2013] [Indexed: 11/17/2022]
|
30
|
Ahern RJ, Hanrahan JP, Tobin JM, Ryan KB, Crean AM. Comparison of fenofibrate–mesoporous silica drug-loading processes for enhanced drug delivery. Eur J Pharm Sci 2013; 50:400-9. [DOI: 10.1016/j.ejps.2013.08.026] [Citation(s) in RCA: 81] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2013] [Revised: 08/09/2013] [Accepted: 08/15/2013] [Indexed: 11/28/2022]
|
31
|
Xie M, Shi H, Li Z, Shen H, Ma K, Li B, Shen S, Jin Y. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging. Colloids Surf B Biointerfaces 2013; 110:138-47. [DOI: 10.1016/j.colsurfb.2013.04.009] [Citation(s) in RCA: 88] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2013] [Revised: 03/25/2013] [Accepted: 04/12/2013] [Indexed: 10/26/2022]
|
32
|
Wang SJ, Chen CS, Chen LC. Prussian blue nanoparticles as nanocargoes for delivering DNA drugs to cancer cells. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS 2013; 14:044405. [PMID: 27877590 PMCID: PMC5090316 DOI: 10.1088/1468-6996/14/4/044405] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2013] [Accepted: 07/17/2013] [Indexed: 05/22/2023]
Abstract
We studied the use of Prussian blue nanoparticles (PBNPs) as novel nanocarriers for sending DNA drugs into cancer cells. 11-mercaptoundecanoic acid (MUA) was used to functionalize the surfaces of PBNPs (nanocubes with an average dimension of 75 nm) for subsequent covalent grafting of a 33-mer DNA drug with a FAM reporter at the 3' end. The PBNPs synthesis and DNA drug conjugation were characterized by transmission electron microscopy (TEM) and Fourier-transform infrared absorption (FTIR), respectively. The drug was a decoy oligodeoxynucleotide (dODN) that inhibits the signal transducer and activator of transcription 3 (STAT3). The DNA-PBNPs drug (dODN@MUA-PBNPs) was delivered into human prostate carcinoma 22rv1 cells by endocytosis in vitro as confirmed by confocal fluorescence microscopy. MTT cell viability assays were carried out to assess the effect of the DNA-PBNPs drug. The results showed that the dODN molecules were successfully conjugated to the MUA modified PBNPs via amide and/or disulfide bond formation and could thus be successfully delivered into the cancer cells. The control experiments showed that the unconjugated dODN molecules were not able to enter the cancer cells no matter whether non-functionalized PBNPs were present or not. It was also found that the DNA-PBNPs drugs were internalized and then distributed homogeneously throughout the cell, including cytoplasmic and nucleic regions, after endocytosis. The cancer cell-killing ability increased with the amount of dODN conjugated on PBNPs and the dosage of DNA-PBNPs drug internalized.
Collapse
Affiliation(s)
| | | | - Lin-Chi Chen
- Department of Bio-Industrial Mechatronics Engineering, National Taiwan University, No. 1, Section 4, Roosevelt Road, Taipei 10617, Taiwan, Republic of China
| |
Collapse
|
33
|
Amritha Rammohan B, Tayal L, Kumar A, Sivakumar S, Sharma A. Fabrication of polymer-modified monodisperse mesoporous carbon particles by template-based approach for drug delivery. RSC Adv 2013. [DOI: 10.1039/c2ra22261b] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
34
|
The influence of supercritical carbon dioxide (SC-CO2) processing conditions on drug loading and physicochemical properties. Int J Pharm 2012; 439:92-9. [DOI: 10.1016/j.ijpharm.2012.09.047] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2012] [Accepted: 09/24/2012] [Indexed: 11/19/2022]
|